Cargando…
Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease
With the number of cases of coronavirus disease-2019 (COVID-19) increasing rapidly, the World Health Organization (WHO) has recommended that patients with mild or moderate symptoms could be released from quarantine without nucleic acid retesting, and self-isolate in the community. This may pose a po...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Zhejiang University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042531/ https://www.ncbi.nlm.nih.gov/pubmed/33835766 http://dx.doi.org/10.1631/jzus.B2000608 |
_version_ | 1783678144288391168 |
---|---|
author | YUAN, Shijin PAN, Yong XIA, Yan ZHANG, Yan CHEN, Jiangnan ZHENG, Wei XU, Xiaoping XIE, Xinyou ZHANG, Jun |
author_facet | YUAN, Shijin PAN, Yong XIA, Yan ZHANG, Yan CHEN, Jiangnan ZHENG, Wei XU, Xiaoping XIE, Xinyou ZHANG, Jun |
author_sort | YUAN, Shijin |
collection | PubMed |
description | With the number of cases of coronavirus disease-2019 (COVID-19) increasing rapidly, the World Health Organization (WHO) has recommended that patients with mild or moderate symptoms could be released from quarantine without nucleic acid retesting, and self-isolate in the community. This may pose a potential virus transmission risk. We aimed to develop a nomogram to predict the duration of viral shedding for individual COVID-19 patients. This retrospective multicentric study enrolled 135 patients as a training cohort and 102 patients as a validation cohort. Significant factors associated with the duration of viral shedding were identified by multivariate Cox modeling in the training cohort and combined to develop a nomogram to predict the probability of viral shedding at 9, 13, 17, and 21 d after admission. The nomogram was validated in the validation cohort and evaluated by concordance index (C-index), area under the curve (AUC), and calibration curve. A higher absolute lymphocyte count (P=0.001) and lymphocyte-to-monocyte ratio (P=0.013) were correlated with a shorter duration of viral shedding, while a longer activated partial thromboplastin time (P=0.007) prolonged the viral shedding duration. The C-indices of the nomogram were 0.732 (95% confidence interval (CI): 0.685‒0.777) in the training cohort and 0.703 (95% CI: 0.642‒0.764) in the validation cohort. The AUC showed a good discriminative ability (training cohort: 0.879, 0.762, 0.738, and 0.715 for 9, 13, 17, and 21 d; validation cohort: 0.855, 0.758, 0.728, and 0.706 for 9, 13, 17, and 21 d), and calibration curves were consistent between outcomes and predictions in both cohorts. A predictive nomogram for viral shedding duration based on three easily accessible factors was developed to help estimate appropriate self-isolation time for patients with mild or moderate symptoms, and to control virus transmission. |
format | Online Article Text |
id | pubmed-8042531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Zhejiang University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-80425312021-04-16 Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease YUAN, Shijin PAN, Yong XIA, Yan ZHANG, Yan CHEN, Jiangnan ZHENG, Wei XU, Xiaoping XIE, Xinyou ZHANG, Jun J Zhejiang Univ Sci B Research Article With the number of cases of coronavirus disease-2019 (COVID-19) increasing rapidly, the World Health Organization (WHO) has recommended that patients with mild or moderate symptoms could be released from quarantine without nucleic acid retesting, and self-isolate in the community. This may pose a potential virus transmission risk. We aimed to develop a nomogram to predict the duration of viral shedding for individual COVID-19 patients. This retrospective multicentric study enrolled 135 patients as a training cohort and 102 patients as a validation cohort. Significant factors associated with the duration of viral shedding were identified by multivariate Cox modeling in the training cohort and combined to develop a nomogram to predict the probability of viral shedding at 9, 13, 17, and 21 d after admission. The nomogram was validated in the validation cohort and evaluated by concordance index (C-index), area under the curve (AUC), and calibration curve. A higher absolute lymphocyte count (P=0.001) and lymphocyte-to-monocyte ratio (P=0.013) were correlated with a shorter duration of viral shedding, while a longer activated partial thromboplastin time (P=0.007) prolonged the viral shedding duration. The C-indices of the nomogram were 0.732 (95% confidence interval (CI): 0.685‒0.777) in the training cohort and 0.703 (95% CI: 0.642‒0.764) in the validation cohort. The AUC showed a good discriminative ability (training cohort: 0.879, 0.762, 0.738, and 0.715 for 9, 13, 17, and 21 d; validation cohort: 0.855, 0.758, 0.728, and 0.706 for 9, 13, 17, and 21 d), and calibration curves were consistent between outcomes and predictions in both cohorts. A predictive nomogram for viral shedding duration based on three easily accessible factors was developed to help estimate appropriate self-isolation time for patients with mild or moderate symptoms, and to control virus transmission. Zhejiang University Press 2021-04-15 /pmc/articles/PMC8042531/ /pubmed/33835766 http://dx.doi.org/10.1631/jzus.B2000608 Text en © Zhejiang University Press 2021 |
spellingShingle | Research Article YUAN, Shijin PAN, Yong XIA, Yan ZHANG, Yan CHEN, Jiangnan ZHENG, Wei XU, Xiaoping XIE, Xinyou ZHANG, Jun Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease |
title | Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease |
title_full | Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease |
title_fullStr | Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease |
title_full_unstemmed | Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease |
title_short | Development and validation of an individualized nomogram for early prediction of the duration of SARS-CoV-2 shedding in COVID-19 patients with non-severe disease |
title_sort | development and validation of an individualized nomogram for early prediction of the duration of sars-cov-2 shedding in covid-19 patients with non-severe disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042531/ https://www.ncbi.nlm.nih.gov/pubmed/33835766 http://dx.doi.org/10.1631/jzus.B2000608 |
work_keys_str_mv | AT yuanshijin developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease AT panyong developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease AT xiayan developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease AT zhangyan developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease AT chenjiangnan developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease AT zhengwei developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease AT xuxiaoping developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease AT xiexinyou developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease AT zhangjun developmentandvalidationofanindividualizednomogramforearlypredictionofthedurationofsarscov2sheddingincovid19patientswithnonseveredisease |